Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 796

BillFederalHouseIn Committee
Second Chance for Moms Act
About This Bill
Committee
Latest Action · January 28, 2025
Referred to the House Committee on Energy and Commerce.
Introduced
January 28, 2025
Cosponsors (13)
0D 13R
View PDF ↗

Full Text

Highlight any text to annotate
119th (2025–2027)
H.R. 796
Second Chance for Moms Act of 2025This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

https://www.congress.gov/119/bills/hr796/BILLS-119hr796ih.htm

https://www.congress.gov/119/bills/hr796/BILLS-119hr796ih.htm

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.